Neurofix Pharma

Private

SalamancaHealthcare & Life Scienceshttps://neurofixpharma.com/

Last Round

Crowdfunding

May 19, 2023

Est. Valuation

$23.79M

Total Funding Raised

$5.84M

Company Overview

Neurofix Pharma is a biotechnology company that researches and develops lipid-based therapies for the treatment of central nervous system disorders, including neuropathic pain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoveryneuropathic painclinical trialsspinal cord injurybiotechNFX-88therapeutic developmentclinical-stage biotechpain managementdrug developmentpharmaceutical R&Dnon-addictive pain reliefbiotech startupneurology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurofix Pharma Comps

Public and private peers based on sector, stage, and business model.

Neurofix Pharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurofix Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Crowdfunding	May 19, 2023
VC Round	Nov 16, 2022
Crowdfunding	Jan 18, 2022
Crowdfunding	Sep 8, 2021
VC Round	Aug 14, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

JOSE FRANCISCO SANCHEZ IGLESIAS

Chief Financial Officer, Director financiero

Executive Team

Neurofix Pharma Investors

Notable investors and investment history

Neurofix Pharma investors
Investor	Rounds
Nowture	VC Round
Fellow Funders	Crowdfunding
Capital Cell	Crowdfunding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 18, 2022
Raised $4M led by Capital Cell

View all signals

Neurofix Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Neurofix Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurofix Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalamanca

Employee Range4

Year Founded2015

Last FundingMay 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.